Wipfli Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Wipfli Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$24K	Buy	+2,950	New	+$26.1K	﹤0.01%	1502

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Wipfli Financial Advisors's TEVA Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2022: 2,950 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #1502 among its holdings.

430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Wipfli Financial Advisors held 2,950 shares of Teva Pharmaceuticals worth $24K as of Q3 2022.
Teva Pharmaceuticals was a new Wipfli Financial Advisors position in Q3 2022.
Teva Pharmaceuticals made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1502 holding.
430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.